Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis.

Bonafede, Machaon; Mehta, Rina; Kim, Gilwan; Sruti, Ila; Tian, Marc; Pelletier, Corey; Goldfarb, Neil

Bonafede, Machaon; Mehta, Rina; Kim, Gilwan; Sruti, Ila; Tian, Marc; Pelletier, Corey; Goldfarb, Neil.

Afiliação

Bonafede M; IBM Watson Health, 75 Binney St, Cambridge, MA, 02142, USA.
Mehta R; Bristol-Myers Squibb Company, Princeton, NJ, USA.
Kim G; IBM Watson Health, 75 Binney St, Cambridge, MA, 02142, USA. kimgi@us.ibm.com.
Sruti I; IBM Watson Health, 75 Binney St, Cambridge, MA, 02142, USA.
Tian M; Bristol-Myers Squibb Company, Princeton, NJ, USA.
Pelletier C; Bristol-Myers Squibb Company, Princeton, NJ, USA.
Goldfarb N; Greater Philadelphia Business Coalition on Health, Philadelphia, PA, USA.

Pharmacoecon Open ; 5(1): 23-34, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33051856

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google